Kobayashi Pharmaceutical Group offers a wide variety of products in the fields of pharmaceuticals, air fresheners, nutritional supplements (dietary supplements), and daily necessities.
Kyushu University analysis found multiple harmful substances beyond puberulic acid in Kobayashi Pharmaceutical's red yeast rice supplement, including compounds potentially toxic to liver and kidneys.
Child supplement recall in Kumamoto due to red yeast rice
Health food maker Morikawa Kenko-do in Kosa, Kumamoto Prefecture, recalls children's supplements using Kobayashi Pharmaceutical's red yeast rice as an ingredient.
Noevia, a cosmetics company in Kobe, announced voluntary recall of their DHA & EPA supplement containing Kobayashi Pharmaceutical's red yeast rice. No health issues reported yet.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.